InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Wednesday, 08/12/2020 8:17:53 PM

Wednesday, August 12, 2020 8:17:53 PM

Post# of 233268
On conf call - this is from SA comments.
Think about it - this was supposed to RANTES disease and CCR5 - why it was not even mentioned?

Was it not measured?
Were the readings did not support the RANTES theory?
Did NP dropped Dr BP after the results or finding that it is not RANTES disease?
Or BP dropped NP after they decided not to use CCR5?readings?


———-
Did anyone notice what was MISSING from the call? ANY mention of the results for:
"Change from baseline in serum cytokine and chemokine levels
Change from baseline in CCR5 receptor occupancy levels for Tregs and macrophages
Change from baseline in CD3+, CD4+ and CD8+ T cell count"


THOSE are actually the most IMPORTANT numbers of the while trial! THOSE are the numbers that would indicate whether leronlimab is actually at doing ANYTHING at ALL.


The FACT that the company WON'T discuss ANY of those numbers indicates that NONE of them were significantly changed and, THEREFORE, leronlimab didn't do SQUAT of what it is allegedly SUPPOSED to do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News